Np mrd loader

Record Information
Version1.0
Created at2021-06-20 21:42:47 UTC
Updated at2021-06-30 00:12:25 UTC
NP-MRD IDNP0039217
Secondary Accession NumbersNone
Natural Product Identification
Common Nameritterazine X
Provided ByJEOL DatabaseJEOL Logo
Description(2S,3'S,3''S,3'aS,4'S,4''S,5'R,5'''S,6''R,6'aS,7''R,8''R,9''S,10''R,12''S,15''R,18''S,24''S,25''S,29''R,32''S)-4',6''-dihydroxy-5'''-(hydroxymethyl)-3',3'',4',5,5,5''',7'',9'',24''-nonamethyl-3'a,4',6',6'a-tetrahydro-3'H-trispiro[oxolane-2,2'-cyclopenta[b]furan-5',28''-[11]oxa-[21,35]diazanonacyclo[18.15.0.0³,¹⁸.0⁴,¹⁵.0⁷,¹⁴.0⁸,¹².0²²,³⁴.0²⁴,³².0²⁵,²⁹]Pentatriacontane-10'',2'''-oxolane]-1''(20''),13'',21'',34''-tetraen-27''-one belongs to the class of organic compounds known as prostaglandins and related compounds. These are unsaturated carboxylic acids consisting of a 20 carbon skeleton that also contains a five member ring, and are based upon the fatty acid arachidonic acid. ritterazine X is found in Ritterella tokioka. It was first documented in 2002 (PMID: 33651529). Based on a literature review a significant number of articles have been published on (2S,3'S,3''S,3'aS,4'S,4''S,5'R,5'''S,6''R,6'aS,7''R,8''R,9''S,10''R,12''S,15''R,18''S,24''S,25''S,29''R,32''S)-4',6''-dihydroxy-5'''-(hydroxymethyl)-3',3'',4',5,5,5''',7'',9'',24''-nonamethyl-3'a,4',6',6'a-tetrahydro-3'H-trispiro[oxolane-2,2'-cyclopenta[b]furan-5',28''-[11]oxa-[21,35]diazanonacyclo[18.15.0.0³,¹⁸.0⁴,¹⁵.0⁷,¹⁴.0⁸,¹².0²²,³⁴.0²⁴,³².0²⁵,²⁹]Pentatriacontane-10'',2'''-oxolane]-1''(20''),13'',21'',34''-tetraen-27''-one (PMID: 33079503) (PMID: 26389513) (PMID: 26389498) (PMID: 26389454) (PMID: 26389451) (PMID: 26389436).
Structure
Thumb
SynonymsNot Available
Chemical FormulaC54H76N2O8
Average Mass881.2080 Da
Monoisotopic Mass880.56017 Da
IUPAC Name(2S,3'S,3''S,3'aS,4'S,4''S,5'R,5'''S,6''R,6'aS,7''R,8''R,9''S,10''R,12''S,15''R,18''S,24''S,25''S,29''R,32''S)-4',6''-dihydroxy-5'''-(hydroxymethyl)-3',3'',4',5,5,5''',7'',9'',24''-nonamethyl-3'a,4',6',6'a-tetrahydro-3'H-trispiro[oxolane-2,2'-cyclopenta[b]furan-5',28''-[11]oxa-[21,35]diazanonacyclo[18.15.0.0^{3,18}.0^{4,15}.0^{7,14}.0^{8,12}.0^{22,34}.0^{24,32}.0^{25,29}]pentatriacontane-10'',2'''-oxolane]-1''(35''),13'',20'',22''(34'')-tetraen-27''-one
Traditional Name(2S,3'S,3''S,3'aS,4'S,4''S,5'R,5'''S,6''R,6'aS,7''R,8''R,9''S,10''R,12''S,15''R,18''S,24''S,25''S,29''R,32''S)-4',6''-dihydroxy-5'''-(hydroxymethyl)-3',3'',4',5,5,5''',7'',9'',24''-nonamethyl-3',3'a,6',6'a-tetrahydrotrispiro[oxolane-2,2'-cyclopenta[b]furan-5',28''-[11]oxa-[21,35]diazanonacyclo[18.15.0.0^{3,18}.0^{4,15}.0^{7,14}.0^{8,12}.0^{22,34}.0^{24,32}.0^{25,29}]pentatriacontane-10'',2'''-oxolane]-1''(35''),13'',20'',22''(34'')-tetraen-27''-one
CAS Registry NumberNot Available
SMILES
[H]OC([H])([H])[C@]1(O[C@]2(O[C@@]3([H])C([H])=C4[C@]5([H])C([H])([H])C([H])([H])[C@@]6([H])C([H])([H])C7=NC8=C(N=C7C([H])([H])[C@]6(C([H])([H])[H])[C@@]5([H])C([H])([H])[C@@]([H])(O[H])[C@]4(C([H])([H])[H])[C@@]3([H])[C@]2([H])C([H])([H])[H])C([H])([H])[C@]2([H])C([H])([H])C([H])([H])[C@]3([H])[C@]([H])(C([H])([H])C(=O)[C@]33C([H])([H])[C@]4([H])O[C@@]5(OC(C([H])([H])[H])(C([H])([H])[H])C([H])([H])C5([H])[H])[C@@]([H])(C([H])([H])[H])[C@]4([H])[C@@]3(O[H])C([H])([H])[H])[C@@]2(C([H])([H])[H])C8([H])[H])C([H])([H])C1([H])[H])C([H])([H])[H]
InChI Identifier
InChI=1S/C54H76N2O8/c1-27-44-40(61-54(27)17-15-47(5,26-57)64-54)20-34-31-12-10-29-18-36-38(23-48(29,6)33(31)21-42(58)50(34,44)8)55-37-19-30-11-13-32-35(49(30,7)24-39(37)56-36)22-43(59)52(32)25-41-45(51(52,9)60)28(2)53(62-41)16-14-46(3,4)63-53/h20,27-33,35,40-42,44-45,57-58,60H,10-19,21-26H2,1-9H3/t27-,28-,29-,30-,31+,32+,33-,35-,40-,41-,42+,44-,45-,47-,48-,49-,50+,51-,52-,53-,54+/m0/s1
InChI KeyZFHSBZLNCXETTI-ZHNRSNCKSA-N
Experimental Spectra
Spectrum TypeDescriptionDepositor EmailDepositor OrganizationDepositorDeposition DateView
1D NMR13C NMR Spectrum (1D, 500 MHz, C5D5N, simulated)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 500 MHz, C5D5N, simulated)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 100 MHz, C5D5N, simulated)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 100 MHz, C5D5N, simulated)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 200 MHz, C5D5N, simulated)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 200 MHz, C5D5N, simulated)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 300 MHz, C5D5N, simulated)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 300 MHz, C5D5N, simulated)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 400 MHz, C5D5N, simulated)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 400 MHz, C5D5N, simulated)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 600 MHz, C5D5N, simulated)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 600 MHz, C5D5N, simulated)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 700 MHz, C5D5N, simulated)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 700 MHz, C5D5N, simulated)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 800 MHz, C5D5N, simulated)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 800 MHz, C5D5N, simulated)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 900 MHz, C5D5N, simulated)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 900 MHz, C5D5N, simulated)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 1000 MHz, C5D5N, simulated)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 1000 MHz, C5D5N, simulated)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
Predicted Spectra
Not Available
Chemical Shift Submissions
Not Available
Species
Species of Origin
Species NameSourceReference
Ritterella tokiokaJEOL database
    • Fukuzawa, S., et al, J. Org. Chem. 62, 4484 (1997)
Chemical Taxonomy
Description Belongs to the class of organic compounds known as prostaglandins and related compounds. These are unsaturated carboxylic acids consisting of a 20 carbon skeleton that also contains a five member ring, and are based upon the fatty acid arachidonic acid.
KingdomOrganic compounds
Super ClassLipids and lipid-like molecules
ClassFatty Acyls
Sub ClassEicosanoids
Direct ParentProstaglandins and related compounds
Alternative Parents
Substituents
  • Prostaglandin skeleton
  • 12-hydroxysteroid
  • Hydroxysteroid
  • Steroid
  • Phenazine
  • Ketal
  • Pyrazine
  • Cyclic alcohol
  • Heteroaromatic compound
  • Tertiary alcohol
  • Tetrahydrofuran
  • Ketone
  • Secondary alcohol
  • Oxacycle
  • Acetal
  • Azacycle
  • Organoheterocyclic compound
  • Alcohol
  • Hydrocarbon derivative
  • Primary alcohol
  • Organic oxide
  • Organooxygen compound
  • Organonitrogen compound
  • Organopnictogen compound
  • Organic oxygen compound
  • Organic nitrogen compound
  • Carbonyl group
  • Aromatic heteropolycyclic compound
Molecular FrameworkAromatic heteropolycyclic compounds
External DescriptorsNot Available
Physical Properties
StateNot Available
Experimental Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Predicted Properties
PropertyValueSource
logP5.87ALOGPS
logP5.43ChemAxon
logS-6.2ALOGPS
pKa (Strongest Acidic)13.82ChemAxon
pKa (Strongest Basic)1.52ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count10ChemAxon
Hydrogen Donor Count3ChemAxon
Polar Surface Area140.46 ŲChemAxon
Rotatable Bond Count1ChemAxon
Refractivity241.22 m³·mol⁻¹ChemAxon
Polarizability104.82 ųChemAxon
Number of Rings13ChemAxon
BioavailabilityNoChemAxon
Rule of FiveNoChemAxon
Ghose FilterNoChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
HMDB IDNot Available
DrugBank IDNot Available
Phenol Explorer Compound IDNot Available
FoodDB IDNot Available
KNApSAcK IDNot Available
Chemspider ID8804863
KEGG Compound IDNot Available
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkNot Available
METLIN IDNot Available
PubChem Compound10629501
PDB IDNot Available
ChEBI IDNot Available
Good Scents IDNot Available
References
General References
  1. Authors unspecified: Curcumin (Curcuma, Turmeric) and Cancer (PDQ(R)): Health Professional Version. 2002. [PubMed:33651529 ]
  2. Authors unspecified: Cancer Therapy Interactions With Foods and Dietary Supplements (PDQ(R)): Health Professional Version. 2002. [PubMed:33079503 ]
  3. Authors unspecified: Planning the Transition to End-of-Life Care in Advanced Cancer (PDQ(R)): Health Professional Version. 2002. [PubMed:26389513 ]
  4. Authors unspecified: Childhood Central Nervous System Germ Cell Tumors Treatment (PDQ(R)): Health Professional Version. 2002. [PubMed:26389498 ]
  5. Authors unspecified: Childhood Acute Myeloid Leukemia/Other Myeloid Malignancies Treatment (PDQ(R)): Health Professional Version. 2002. [PubMed:26389454 ]
  6. Authors unspecified: Cancer Prevention Overview (PDQ(R)): Health Professional Version. 2002. [PubMed:26389451 ]
  7. Authors unspecified: Spirituality in Cancer Care (PDQ(R)): Health Professional Version. 2002. [PubMed:26389436 ]
  8. Authors unspecified: Oral Cavity, Oropharyngeal, Hypopharyngeal, and Laryngeal Cancer Prevention (PDQ(R)): Health Professional Version. 2002. [PubMed:26389416 ]
  9. Authors unspecified: Adjustment to Cancer: Anxiety and Distress (PDQ(R)): Health Professional Version. 2002. [PubMed:26389397 ]
  10. Authors unspecified: Cancer Pain (PDQ(R)): Health Professional Version. 2002. [PubMed:26389387 ]
  11. Fukuzawa, S., et al. (1997). Fukuzawa, S., et al, J. Org. Chem. 62, 4484 (1997). J. Org. Chem..